10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Plasma homocysteine and the risk of venous thromboembolism: insights from the FIELD study.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The lipid-lowering effect of fenofibrate is accompanied by a rise in plasma homocysteine (HCY), a potential risk factor for venous thromboembolism (VTE).This study investigated the relationship between HCY and the risk of VTE in patients treated with fenofibrate.

          Related collections

          Author and article information

          Journal
          Clin Chem Lab Med
          Clinical chemistry and laboratory medicine
          Walter de Gruyter GmbH
          1437-4331
          1434-6621
          Dec 2012
          : 50
          : 12
          Affiliations
          [1 ] Department of Clinical Biochemistry , Royal Prince Alfred Hospital, Sydney, Australia.
          Article
          /j/cclm.ahead-of-print/cclm-2012-0078/cclm-2012-0078.xml
          10.1515/cclm-2012-0078
          23093273
          30878ed9-30ac-4656-a720-523bdce199e2
          History

          Comments

          Comment on this article